In 2026, the disposable medical supplies industry is undergoing a green transformation driven by the adoption of biodegradable and plant-based materials to address plastic waste and carbon reduction goals. Traditional petroleum-based plastics (PVC, PP, PE) are being replaced by PLA (polylactic acid), PCL, starch-based composites, and bagasse (sugarcane waste) materials, with products like biodegradable syringes, wound dressings, and surgical instruments gaining regulatory approvals.
Leading examples include NewGen’s bagasse-based skin stapler, which reduces plastic usage by 69% and cuts CO₂ emissions by 50% compared to traditional plastic models. Chinese manufacturers have achieved mass production of PLA-based disposable gloves and catheters, with output reaching 180 million sets in 2025 (up 210% YoY). These materials offer full biodegradability (3–6 months under industrial composting), biocompatibility, and safety (free of BPA, phthalates, and mercury).
Regulatory support is accelerating adoption: the EU MDR (Medical Device Regulation) now prioritizes eco-friendly products, while the FDA has approved 12 biodegradable disposable medical devices since 2025. Hospitals worldwide are setting plastic reduction targets (30%–50% by 2030), creating strong demand for sustainable alternatives. Industry experts predict that biodegradable disposable medical supplies will capture 25% of the global market by 2030, driven by environmental policies and corporate sustainability goals.